M2 macrophages contribute to cell proliferation and migration of breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M2 macrophages contribute to cell proliferation and migration of breast cancer
Authors
Keywords
-
Journal
CELL BIOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-16
DOI
10.1002/cbin.11528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circular RNA circ‐EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR‐1299‐mediated IRF7 activation
- (2020) Ling Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- TARBP2 inhibits IRF7 activation by suppressing TRAF6-mediated K63-linked ubiquitination of IRF7
- (2019) Ting Ling et al. MOLECULAR IMMUNOLOGY
- Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion
- (2019) Fengkai Li et al. CANCER RESEARCH
- Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway
- (2019) Zi Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression
- (2019) Hong-Fa Xu et al. Cancer Management and Research
- BTXA regulates the epithelial–mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2
- (2019) Zhanying Hou et al. BIOSCIENCE REPORTS
- MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis
- (2019) Mengyun Ke et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage
- (2019) Ziqi Meng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- Hsa‐miR‐1587 G‐quadruplex formation and dimerization induced by NH 4 + , molecular crowding environment and jatrorrhizine derivatives
- (2018) Wei Tan et al. TALANTA
- Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
- (2018) Qiang Lan et al. ONCOGENE
- Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer
- (2017) Nathan Touati et al. EUROPEAN JOURNAL OF CANCER
- Interferon regulatory factors: A key to tumour immunity
- (2017) Yan-Jie Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
- (2017) Xinrong Luo et al. Oncotarget
- Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
- (2017) Xixi Zhao et al. Oncotarget
- Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression
- (2011) Sanjib Banerjee et al. CANCER RESEARCH
- IRF7: activation, regulation, modification and function
- (2011) S Ning et al. GENES AND IMMUNITY
- The IRF Family Transcription Factors in Immunity and Oncogenesis
- (2008) Tomohiko Tamura et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation